Johnson & Johnson DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Johnson & Johnson has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
Johnson & Johnson's upcoming annual meeting will address director elections, executive compensation, and shareholder proposals on severance packages and human rights impact assessments.
NYSE
Johnson & Johnson has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.
NYSE
A shareholder proposal regarding the impact of extended patent exclusivities on patient access has been withdrawn from Johnson & Johnson's upcoming Annual Meeting.
NYSE
DEF 14A: Johnson & Johnson's 2024 Proxy Statement: Board Elections, Executive Pay, and Shareholder Proposals
Johnson & Johnson's 2024 proxy statement outlines key governance matters, including director elections, executive compensation, and shareholder proposals.